| Literature DB >> 32309097 |
Tatyana A Petukhova1, Kristina Navrazhina1, Kira Minkis1.
Abstract
BACKGROUND: The keystone perforator flap design has been gaining popularity for reconstruction of cutaneous defects due to its robust vascular supply and high rates of flap survival. However, the design requires significant tissue mobilization relative to the defect and is consequently technically demanding, time intensive, and has associated morbidity. We present a novel, simplified modification of the keystone flap that may increase its reconstructive applications.Entities:
Year: 2020 PMID: 32309097 PMCID: PMC7159958 DOI: 10.1097/GOX.0000000000002654
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Video 1.Video 1 from “The V-Y Hemi-keystone Advancement Flap: A Novel and Simplified Reconstructive Modification”
Fig. 1.Illustration of the V-Y hemi-keystone advancement flap technique. Illustration by Anatomy By Design, Inc.
Fig. 2.Representative outcome of the V-Y hemi-keystone advancement flap reconstruction in an 80-year-old woman who presented for excision of malignant melanoma on the right lower leg, with final defect measuring 4.5 × 3.6 cm2 extending to the fascial plane, and reconstructed with a V-Y hemi-keystone advancement flap measuring 12.0 × 8.5 cm2. All surgical wounds were dressed with a pressure dressing for 48 hours with suture removal at 2–3 weeks; with the exception of below-the-knee reconstructions, which were wrapped in a weekly zinc oxide compression dressing to decrease swelling.
Patient Demographics and Clinical Characteristics
| Characteristics | Value |
|---|---|
| Total participants, n | 73 |
| Male sex, n (%) | 36 (49.3) |
| Age, y, mean (SEM) | 71.1 (1.5) |
| Comorbidities, n (%) | |
| Diabetes | 5 (6.9) |
| Smoking | 5 (6.9) |
| Anticoagulants | 30 (41.1) |
Characteristics and Outcomes Following Reconstruction with the V-Y Hemi-keystone Advancement Flap
| Characteristics | Value |
|---|---|
| Total cases | 86 |
| Diagnosis, n (%) | |
| SCC | 39 (45.3) |
| BCC | 33 (38.4) |
| Melanoma | 8 (9.3) |
| Atypical nevus | 3 (3.5) |
| Others | 3 (3.5) |
| Tumor location, n (%) | |
| Trunk | 2 (2.3) |
| Upper extremity | 9 (10.5) |
| Lower extremity | 75 (87.2) |
| Defect area cm2, mean (SEM) | 5.8 (0.6) |
| Reconstruction area cm2, mean (SEM) | 53.5 (4.2) |
| Follow-up time, weeks, mean (SEM) | 26.3 (2.5) |
| Complications, n (%) | 6 (7.0) |
| Infection | 2 (2.3) |
| Dehiscence | 1 (1.2) |
| Infection + dehiscence | 3 (3.5) |
| Hematoma | 0 (0) |
| Flap failure | 0 (0) |
BCC, basal cell carcinoma; SCC, squamous cell carcinoma.